Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €20.80 EUR
Change Today +0.127 / 0.61%
Volume 180.0
DY8 On Other Exchanges
As of 12:25 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gustav A. Christensen

Chief Executive Officer, President and Director,Dyax Corp.
AgeTotal Calculated CompensationThis person is connected to 17 board members in 3 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Gustav A. Christensen has been Chief Executive Officer and President of Dyax Corp. since January 1, 2009. Mr. Christensen serves as Chief Executive Officer and Chairman of the United States Office at affentranger associates sa, Investment arm. Mr. Christensen joined Dyax in April 2007. He has been Chief Executive Officer of Phylos, Inc. since August 2000. He served as Managing Director of Apeiron Partners, LLC, a boutique life sciences investment bank, from 2005 ...

Read Full Background

Corporate Headquarters*

55 Network Drive
Burlington, Massachusetts 01803

United States

Phone: 617-225-2500
Fax: 617-225-2501

Board Members Memberships*

Chairman of the Board
Chief Executive Officer, President and Director


Harvard Business School
Aarhus Universitet

Other Affiliations*

Annual Compensation*

Total Annual Compensation$636,826

Stock Options*

Restricted Stock Awards$510,000
All Other Compensation$14,922
Exercisable Options4,253,576
Unexercisable Options1,133,334
Total Number of Options5,386,910

Total Compensation*

Total Annual Cash Compensation$1,135,348
Total Short Term Compensation$636,826
Other Long Term Compensation$524,922
Total Calculated Compensation$3,604,948
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DY8:GR €20.80 EUR +0.127


Jon P. Stonehouse Chief Executive Officer, President and Executive Director
BioCryst Pharmaceuticals, Inc.
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYAX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at